|Videos|April 5, 2022
The Quick Neurologic Examination Tool in the PICU: Apirada Thongsing, MD
Author(s)Apirada Thongsing, MD
The resident physician at Montefiore Medical Center shared her experience with the novel and standardized quick examination tool and the data presented at AAN 2022. [WATCH TIME: 3 minutes]
Advertisement
WATCH TIME: 3 minutes
“We focused on 4 domains: mental status, communication, motor function, and cranial nerves (or brainstem reflex). Those were the main things we wanted to focus on, rather than doing a full neuro exam, so it would be easier for us to talk to each other.”
An assessment of a novel and standardized quick neurologic examination (QNE) tool has demonstrated validity for use in neurological examinations of patients in the pediatric intensive care unit (PICU).1
Presented at the 2022 American Academy of Neurology (AAN) Annual Meeting , April 2-7, in Seattle, Washington, by Apirada Thongsing, MD, resident physician, Department of Neurology, Montefiore Medical Center , and colleagues, the QNE displayed good interrater reliability, agreement, and validity in a 23-participant cohort assessed with varying combinations of raters, including resident and attending physicians, and nurses.
The tool includes an evaluation of 4 neurologic domains: the level of consciousness, communication ability, motor function, and cranial nerves. Each domain is scored from 0 to 4, with 0 being worst and 4 being best. As such, total scores range from 0 to 16. The patients in the PICU who were included were aged 2-21 years with a neurologic diagnosis. Validity was determined by comparison of categories between neurologists and nonspecialists, with the comparison between QNE and Glasgow Coma Scale (GCS) or Full Outline of Un-Responsiveness (FOUR) scores conducted with simple linear regression.
Ultimately, between nurse and physician raters, the agreement—assessed by tolerating a total score difference of 1-2—was 68% (tolerance, 1) and 86% (tolerance, 2; n = 22), with strong interrater reliability (𝜅 weighted = 0.92; 𝜅 = 0.24 [95% CI, 0.08-0.4]; P = .004). Additionally, when evaluating these scores in stratified groups (lower, 0-5; middle, 6-11; and upper, 12-16), the agreement between raters was 83% (tolerance, 0).
While on-site at AAN 2022, NeurologyLive® sat down with Thongsing to hear her perspective on the tool and its utility in the PICU. She shared her insight from the assessment and offered a look at the QNE’s potential outside of pediatrics and in other departments, emphasizing the ease and speed of conducting the exam and its ability to improve between-provider communication.
REFERENCE
1. Thongsing A, Coad SD, Miksa M. Reliability and Validity of a Novel Quick Neurologic Exam Tool for Assessing Patients in the Pediatric Intensive Care Unit (PICU). Presented at: AAN Annual Meeting; April 2-7, 2022; Seattle, WA, and virtual.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
3
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
4
NeurologyLive® Brain Games: September 14, 2025
5